Hydrogel-based engineered skeletal muscle grafts normalize heart function early after myocardial infarction.
about
In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin'Human umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivoSwelling equilibrium of dentin adhesive polymers formed on the water-adhesive phase boundary: experiments and micromechanical model.Fate of modular cardiac tissue constructs in a syngeneic rat model.Cell therapies for heart function recovery: focus on myocardial tissue engineering and nanotechnologies.Electrical and Mechanical Strategies to Enable Cardiac Repair and Regeneration.Effects of B-cell lymphoma 2 gene transfer to myoblast cells on skeletal muscle tissue formation using magnetic force-based tissue engineering.Prevascularized microtemplated fibrin scaffolds for cardiac tissue engineering applicationsCell-based therapy for heart failure in rat: double thoracotomy for myocardial infarction and epicardial implantation of cells and biomatrix.Direct-write bioprinting three-dimensional biohybrid systems for future regenerative therapiesCardiac tissue engineering using stem cells.Proangiogenic microtemplated fibrin scaffolds containing aprotinin promote improved wound healing responses.Hydrogel scaffolds for tissue engineering: Progress and challenges.Cardiac fibroblast-derived 3D extracellular matrix seeded with mesenchymal stem cells as a novel device to transfer cells to the ischemic myocardium.Skeletal myoblasts for cardiac repair.Engineering cell platforms for myocardial regeneration.Strategies for tissue engineering cardiac constructs to affect functional repair following myocardial infarction.Cardiac tissue engineering and regeneration using cell-based therapyNano-Enabled Approaches for Stem Cell-Based Cardiac Tissue Engineering.Artificial Cardiac Muscle with or without the Use of Scaffolds.Hepatocyte growth factor-transfected skeletal myoblasts to limit the development of postinfarction heart failure.
P2860
Q26775715-E5027D95-5A7D-434B-860B-706823A87572Q27336125-EC6AD766-A0E3-44FE-ACC5-A8472EC8EEAAQ30421555-210CE8B9-A55F-4015-8214-D2F0E156CB2AQ33734986-995E501A-5A3D-48FE-87BD-9258A3C86146Q35942474-429A5790-5D70-4C4B-9AEB-C8791B6B8433Q36083735-0E97930C-0196-400E-A063-461595E52E74Q36490802-252924DD-5B6A-493E-B73B-041AA6359989Q36661266-8DE2E376-E05A-4AF6-845E-AECC178A4E44Q36788232-5B6B8900-84D8-45B6-BD4D-A53FFB23F17CQ37169254-6833D104-219D-4D62-B80D-5B8DAA09F8B9Q37261443-3E42608F-1AA1-4F19-8A10-12DDF4C21D79Q37465663-B1330084-3258-464E-8216-1368699E2265Q37659227-32F01939-C9FB-47E4-B304-AAC75EDE525DQ37661493-064310A9-E99F-4CA3-84D2-BF99ECCE7F6CQ37810057-D8269A59-3C15-4449-943D-1984AF61A344Q37872006-B924A123-0A01-4341-A48B-A42CAF64ECF7Q37912067-172D2094-4255-42FF-929A-8DEC0A1B384AQ38497140-BB6F29F1-6638-4A3B-924C-BBAAB63F1802Q38839098-51FD6056-B115-4EDD-8231-9E5827E87364Q41509582-348521AC-7A4C-4D69-B224-57C4B65D0776Q45873033-4AF84649-4EC8-4F17-9CC9-AF7A443FC101
P2860
Hydrogel-based engineered skeletal muscle grafts normalize heart function early after myocardial infarction.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Hydrogel-based engineered skel ...... y after myocardial infarction.
@en
Hydrogel-based engineered skel ...... y after myocardial infarction.
@nl
type
label
Hydrogel-based engineered skel ...... y after myocardial infarction.
@en
Hydrogel-based engineered skel ...... y after myocardial infarction.
@nl
prefLabel
Hydrogel-based engineered skel ...... y after myocardial infarction.
@en
Hydrogel-based engineered skel ...... y after myocardial infarction.
@nl
P2093
P1433
P1476
Hydrogel-based engineered skel ...... y after myocardial infarction.
@en
P2093
Erick Ayuni
Hendrik T Tevaearai
Marie-Noëlle Giraud
Stéphane Cook
Thierry P Carrel
P304
P356
10.1111/J.1525-1594.2008.00595.X
P577
2008-07-30T00:00:00Z